We are live on ! Find out more
GP

Geneva Partners Portfolio holdings

AUM $208M
1-Year Est. Return 72.91%
This Fund
S&P 500
This Quarter Est. Return
-11.08%
1 Year Est. Return
+72.91%
3 Year Est. Return
+251.81%
5 Year Est. Return
+429.32%
10 Year Est. Return
AUM
$86.5M
AUM Growth
-$43.7M
Cap. Flow
-$30.5M
Cap. Flow %
-35.25%
Top 10 Hldgs %
41.56%
Holding
94
New
8
Increased
12
Reduced
34
Closed
37

Top Sells

Rank Stock Value
1
BKLN icon
Invesco Senior Loan ETF
BKLN
+$4.19M
2
PX
Praxair Inc
PX
+$3.16M
3
ADSK icon
Autodesk
ADSK
+$3.02M
4
ADBE icon
Adobe
ADBE
+$2.26M
5
PANW icon
Palo Alto Networks
PANW
+$2.24M

Sector Composition

Rank Sector Weight
1 Healthcare 23.11%
2 Financials 12.9%
3 Consumer Discretionary 12.14%
4 Industrials 10.52%
5 Communication Services 10.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.1T
$4.18M 4.84%
80,060
+2,480
+3% +$134K
DIS icon
2
Walt Disney
DIS
$171B
$4.16M 4.81%
37,975
+36,424
+2,348% +$4.14M
NKE icon
3
Nike
NKE
$63.2B
$3.92M 4.53%
52,842
-675
-1% -$50.5K
JPM icon
4
JPMorgan Chase
JPM
$926B
$3.8M 4.39%
38,886
+1,039
+3% +$111K
DG icon
5
Dollar General
DG
$28.2B
$3.74M 4.33%
34,625
+2,605
+8% +$282K
BDX icon
6
Becton Dickinson
BDX
$46.4B
$3.47M 4.01%
15,773
-2,716
-15% -$630K
AMZN icon
7
Amazon
AMZN
$2.46T
$3.31M 3.83%
44,080
+3,840
+10% +$319K
SBUX icon
8
Starbucks
SBUX
$119B
$3.28M 3.79%
+50,920
New +$3.19M
CVS icon
9
CVS Health
CVS
$137B
$3.26M 3.76%
+49,712
New +$3.71M
IVV icon
10
iShares Core S&P 500 ETF
IVV
$862B
$2.84M 3.28%
11,285
+3,161
+39% +$858K
UNH icon
11
UnitedHealth
UNH
$386B
$2.71M 3.13%
10,870
-1,085
-9% -$287K
CAT icon
12
Caterpillar
CAT
$359B
$2.59M 2.99%
20,199
-2,051
-9% -$267K
ABT icon
13
Abbott
ABT
$191B
$2.25M 2.6%
31,038
-1,900
-6% -$134K
PYPL icon
14
PayPal
PYPL
$50.5B
$2.23M 2.57%
26,479
-6,806
-20% -$567K
C icon
15
Citigroup
C
$215B
$2.12M 2.45%
45,285
-24,120
-35% -$1.53M
TMO icon
16
Thermo Fisher Scientific
TMO
$214B
$2.05M 2.37%
9,145
+3,400
+59% +$798K
BAC icon
17
Bank of America
BAC
$433B
$2.01M 2.32%
81,525
+4,500
+6% +$122K
DVY icon
18
iShares Select Dividend ETF
DVY
$24B
$1.93M 2.23%
21,555
-715
-3% -$68.5K
AMGN icon
19
Amgen
AMGN
$211B
$1.84M 2.13%
9,946
+510
+5% +$99.5K
IUSV icon
20
iShares Core S&P US Value ETF
IUSV
$27.4B
$1.8M 2.09%
36,775
-2,015
-5% -$107K
IJH icon
21
iShares Core S&P Mid-Cap ETF
IJH
$121B
$1.8M 2.08%
54,200
-21,065
-28% -$769K
TT icon
22
Trane Technologies
TT
$98.4B
$1.79M 2.07%
19,585
-2,235
-10% -$220K
FDRR icon
23
Fidelity Dividend ETF for Rising Rates
FDRR
$735M
$1.51M 1.74%
+52,570
New +$1.61M
PANW icon
24
Palo Alto Networks
PANW
$253B
$1.49M 1.72%
47,478
-71,910
-60% -$2.24M
QUAL icon
25
iShares MSCI USA Quality Factor ETF
QUAL
$45.9B
$1.43M 1.66%
18,660
+14,660
+367% +$1.22M

Similar funds

Geneva Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Geneva Partners held 94 positions worth $86.5M, down 34% from $130M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Geneva Partners withdrew a net $30.5M in Q4 2018, closing 37 positions and reducing 34 holdings. Its most notable exit was Invesco Senior Loan ETF, an estimated $4.19M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Geneva Partners opened a new position in CVS Health worth $3.26M.

  • Geneva Partners's largest Q4 2018 buy was CVS Health: 49,712 shares worth $3.26M.
  • Geneva Partners added most to Walt Disney in Q4 2018, an estimated $4.14M increase.
  • Geneva Partners's biggest Q4 2018 reduction was Palo Alto Networks, cutting an estimated $2.24M.
  • Geneva Partners fully exited Invesco Senior Loan ETF in Q4 2018, selling an estimated $4.19M.
  • Geneva Partners's ten largest holdings make up 42% of its $86.5M portfolio in Q4 2018.
  • Geneva Partners opened 8 new positions and closed 37 in Q4 2018.
  • Geneva Partners's portfolio value fell 34% quarter-over-quarter to $86.5M.

Based on Geneva Partners's 13F filing for Q4 2018, filed 30 Jan 2019.